A phase I/II trial to investigate the quadrivalent influenza vaccine candidate Immunose™ FLU
Phase of Trial: Phase I/II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 07 Feb 2018 According to an Eurocine media release, study is planned to be conducted at five locations throughout Sweden during the present influenza season.
- 07 Feb 2018 Status changed from planning to recruiting, according to an Eurocine media release.
- 15 Jan 2018 New trial record